Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized morphine for dyspnea in advanced IPF
NCT04497831Phase 3Unknown
- Sponsor
- Medical University of Gdańsk
- Start
- Sep 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of morphine hydrochloride in idiopathic pulmonary fibrosis (IPF), sponsored by Medical University of Gdańsk. Status: unknown.
02
Drugs
morphine hydrochloride
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT04497831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04497831.